RnR Market Research

Vaccine Market Forecast by Technology, Type, End User, & Disease Indication in a Research Report Available at RnRMarketResearch.com

RnRMarketResearch.com offers “Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) – Forecasts to 2019” global research report in its store.


Dallas, TX -- (SBWIRE) -- 03/11/2015 -- The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. The global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. Its favorable growth is attributed to the rising prevalence of diseases and increasing number of government initiatives taken for immunization programs worldwide.

Companies profiled in this research report are Glaxosmithkline, PLC., Merck & Co., Inc., SANOFI, Pfizer, Inc., Novartis AG, Bavarian Nordic, CSL Limited, Emergent Biosolutions, Inc., Johnson & Johnson, and Medimmune, LLC. (A Subsidiary of Astrazeneca).

Complete report is available at http://www.rnrmarketresearch.com/vaccine-market-by-technology-types-trend-analysis-by-various-classes-live-attenuated-subunit-toxoid-conjugate-dna-recombinant-vector-synthetic-dentritic-vaccines-and-by-indications-i-market-report.html

Major factors contributing to growth of the vaccines market include rising prevalence of diseases, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Furthermore, government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in November 2014, the U.K. government granted $2 billion (£1.32 billion) to GAVI for the improvement of immunization programs in poor countries. The emerging markets of the Asian region have opened an array of opportunities for the vaccines market. However, low accessibility to vaccines in remote areas and stringent regulatory procedures are expected to restrain the growth of this market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=110437

Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by the industry players over the last three years. In addition, the company profiles comprise the basic views on the key players in the vaccines market and the product portfolios, developments, and strategies adopted by the market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of the future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

This is premium research report priced at US$ 4650 for single user PDF licesne. Inquire for discount on this research report at http://www.rnrmarketresearch.com/contacts/discount?rname=110437

Table of Content for "Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) – Forecasts to 2019" Research Report Includes:

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.4 Key Data From Secondary Sources
2.5 Key Data From Primary Sources
2.6 Key Industry Insights
2.7 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Vaccines Market to Have High Growth Potential
4.2 Global Vaccines Market, By Type
4.3 Global Vaccines Market, By Region
4.4 Vaccines Market, By Disease Indication
4.5 Global Vaccines Market, By End Users
4.6 Lifecycle Analysis, By Region

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics

6 Industry Insights
6.1 Porter's Five Forces Analysis
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.4 Technology Trends
6.5 Investment Analysis
6.6 Regulatory Landscape
6.7 Patent Analysis
6.8 Key Pipeline Products
6.9 Strategic Benchmarking

7 Vaccines Market, By Technology
7.1 Subunit Vaccines
7.2 Live Attenuated Vaccines
7.3 Conjugate Vaccines
7.4 Inactivated Vaccines
7.5 Recombinant Vector Vaccines
7.6 Toxoid Vaccines
7.7 Synthetic Vaccines
7.8 Dendritic Cell Vaccines

8 Vaccines Market, By Type
8.1 Introduction
8.2 Preventive Vaccines
8.3 Therapeutic Vaccines

9 Vaccines Market, By Disease Indication
9.1 Introduction
9.2 Infectious Diseases
9.3 Cancer
9.4 Allergies

10 Vaccines Market, By End User
10.1 Introduction
10.2 Pediatrics
10.3 Adults

11 Global Vaccines Market, By Region
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia
11.5 Rest of the World (ROW)

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends

13 Company Profiles
13.1 Glaxosmithkline, PLC.
13.2 Merck & Co., Inc.
13.4 Pfizer, Inc.
13.5 Novartis AG
13.6 Bavarian Nordic
13.7 CSL Limited
13.8 Emergent Biosolutions, Inc.
13.9 Johnson & Johnson
13.10 Medimmune, LLC. (A Subsidiary of Astrazeneca)

14 Appendix
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Available Customizations
14.4 Related Reports
14.5 Introducing RT: Real-Time Market Intelligence

Explore more reports on 'Biopharmaceutical Market' at http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/biopharmaceutical

About RnR Market Research
RnR Market Research library offers syndicated reports by market research publishers from across the globe. We help you find the most relevant business intelligence from ready-to-buy syndicated market research studies. Not limited to industry reports covering telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, F&B , media and more, RnR Market Research also offers company data, country profiles, trends, information and analysis on the sector of your interest. (http://www.rnrmarketresearch.com/latest_reports )